Double-blind comparison of the two hallucinogens psilocybin and dextromethorphan: similarities and differences in subjective experiences

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Psychopharmacology

• Publication date

  2017-11-07

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-017-4769-4PMID 29116367PMCID PMC6645364
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classic Hallucinogens and Mystical Experiences: Phenomenology and Neural Correlates.

  2018cited by this paper
• Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin

  2017cited by this paper
• Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults

  2017cited by this paper
• Association between serotonin denervation and resting‐state functional connectivity in mild cognitive impairment

  2017cited by this paper
• Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions

  2017cited by this paper
• The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms

  2016cited by this paper
• Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders.

  2016cited by this paper
• Psychedelics

  2016cited by this paper
• Phenomenology, Structure, and Dynamic of Psychedelic States.

  2016cited by this paper
• Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.

  2016cited by this paper
• Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.

  2016cited by this paper
• Preparation and characterization of the 'research chemical' diphenidine, its pyrrolidine analogue, and their 2,2-diphenylethyl isomers.

  2015cited by this paper
• Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin

  2015cited by this paper
• LSD enhances the emotional response to music

  2015cited by this paper
• From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs.

  2014cited by this paper
• The role of 5-HT2A, 5-HT2C and mGlu2 receptors in the behavioral effects of tryptamine hallucinogens N,N-dimethyltryptamine and N,N-diisopropyltryptamine in rats and mice

  2014cited by this paper
• Psilocybin--summary of knowledge and new perspectives.

  2014cited by this paper
• Hallucinogens and Club Drugs

  2014cited by this paper
• Acute cognitive effects of high doses of dextromethorphan relative to triazolam in humans.

  2013cited by this paper
• Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

  2012cited by this paper
• Factor Analysis of the Mystical Experience Questionnaire: A Study of Experiences Occasioned by the Hallucinogen Psilocybin.

  2012cited by this paper
• The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions

  2012influential reference
• High doses of dextromethorphan, an NMDA antagonist, produce effects similar to classic hallucinogens

  2012influential reference
• Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

  2011cited by this paper
• Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

  2011cited by this paper
• The Psychology of Religion: An Empirical Approach

  2011cited by this paper
• Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects

  2011influential reference
• The neurobiology of psychedelic drugs: implications for the treatment of mood disorders

  2010cited by this paper
• Psychometric Evaluation of the Altered States of Consciousness Rating Scale (OAV)

  2010influential reference
• Hallucinogens as discriminative stimuli in animals: LSD, phenethylamines, and tryptamines

  2009cited by this paper
• Human hallucinogen research: guidelines for safety

  2008influential reference
• Emotions evoked by the sound of music: characterization, classification, and measurement.

  2008cited by this paper
• The behavioral pharmacology of hallucinogens.

  2008cited by this paper
• Identification of a serotonin/glutamate receptor complex implicated in psychosis

  2008cited by this paper
• Dextromethorphan

  2008cited by this paper
• Hallucinogens recruit specific cortical 5-HT(2A) receptor-mediated signaling pathways to affect behavior.

  2007cited by this paper
• Relative Abuse Liability of GHB in Humans: A Comparison of Psychomotor, Subjective, and Cognitive Effects of Supratherapeutic Doses of Triazolam, Pentobarbital, and GHB

  2006cited by this paper
• Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance

  2006influential reference
• Psychological Effects of (S)-Ketamine and N,N-Dimethyltryptamine (DMT): A Double-Blind, Cross-Over Study in Healthy Volunteers

  2005influential reference
• Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose–effect study

  2004cited by this paper
• Serotonergic/glutamatergic interactions: the effects of mGlu2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

  2004cited by this paper
• Ketamine: Dreams and Realities

  2004cited by this paper
• A sensitive LC-MS/MS assay for the determination of dextromethorphan and metabolites in human urine--application for drug interaction studies assessing potential CYP3A and CYP2D6 inhibition.

  2002cited by this paper
• The pharmacology of psilocybin

  2002cited by this paper
• [Ketamine--dreams and realities].

  2002cited by this paper
• Serotonin and Hallucinogens

  1999cited by this paper
• Psilocybin induces schizophrenia‐like psychosis in humans via a serotonin‐2 agonist action

  1998cited by this paper
• The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans

  1998cited by this paper
• The Cosmic Serpent: DNA and the Origins of Knowledge

  1998cited by this paper
• Determination of psilocin and 4-hydroxyindole-3-acetic acid in plasma by HPLC-ECD and pharmacokinetic profiles of oral and intravenous psilocybin in man.

  1997cited by this paper
• Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects.

  1995cited by this paper
• Dose-response study of N,N-dimethyltryptamine in humans. II. Subjective effects and preliminary results of a new rating scale.

  1994cited by this paper
• Polymorphic dextromethorphan metabolism: Co‐segregation of oxidative O‐demethylation with debrisoquin hydroxylation

  1985cited by this paper
• The Use of Music in Psychedelic (LSD) Psychotherapy

  1972cited by this paper

• The Effect of Magic Mushroom (Psilocybe azurescens) on Social Interaction, Anxiety‐ and Depressive‐Like Behaviors in Male Rats; the Role of Neuroinflammation, Oxidative Stress, and Neurotrophic Factors

  2026cites this paper
• Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use

  2026cites this paper
• Cannabis, marijuana, hashish, natural and synthetic cannabinoids. Mechanism of action, drug addiction and associated risk factors

  2026cites this paper
• Trip sitting or just sitting? Session facilitators substantially influence psychedelic experiences in clinical trials but not in healthy ones.

  2026cites this paper
• Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial

  2025cites this paper
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneous RE104

  2025cites this paper
• Ketamine-Occasioned Mystical Experience in Veterans with Treatment-Resistant Depression: A Retrospective Exploratory Analysis

  2025cites this paper
• A Toad Less Traveled: Should 5-MeO-DMT Have a Role in Treating Depression?

  2025cites this paper
• The compulsive eating paradigm: can psychedelics help in treating obesity?

  2025cites this paper
• Set and setting in psilocybin-assisted therapy: A qualitative study of patients with cancer and depression.

  2025cites this paper
• Insights on Psychedelics: A Systematic Review of Therapeutic Effects.

  2025cites this paper
• Addressing blinding in classic psychedelic studies with innovative active placebos

  2025cites this paper
• Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence

  2025cites this paper
• Psychedelic Therapy, Positive Emotional Experiences, and the Central Role of Self-Compassion

  2025cites this paper
• Serotonin and psilocybin activate 5-HT1B receptors to suppress cortical signaling through the claustrum

  2025cites this paper
• Setting the Stage for the Inner Journey: Unraveling the Interplay of Contextual Factors and the Intensity of Psychedelic-Induced Ego Dissolution.

  2025cites this paper
• Psilocybin alters visual contextual computations

  2025cites this paper
• Modifying Informed Consent to Help Address Functional Unmasking in Psychedelic Clinical Trials.

  2025cites this paper
• Inducing selflessness through a numadelic virtual reality experience: a preliminary study

  2025cites this paper
• Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.

  2025cites this paper
• Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial

  2024cites this paper
• Enhanced visual contrast suppression during peak psilocybin effects: Psychophysical results from a pilot randomized controlled trial

  2024influential citation
• Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology

  2024influential citation
• Learning how to make use of dissociative therapies

  2024influential citation
• Considering distinct positive emotions in psychedelic science

  2024cites this paper
• The influence of stakeholder interests on safety outcome reporting in psychedelic research and implications for science communication

  2024cites this paper
• Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.

  2024cites this paper
• The Role of Music in Psychedelic-Assisted Therapy: A Comparative Analysis of Neuroscientific Research, Indigenous Entheogenic Ritual, and Contemporary Care Models

  2024cites this paper
• RE104: Synthesis and Activity of a Novel Serotonergic Psychedelic Prodrug of 4-Hydroxy-N,N-diisopropyltryptamine

  2024cites this paper
• Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis

  2024cites this paper
• Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.

  2024cites this paper
• Psychedelic Therapy: A Primer for Primary Care Clinicians—Psilocybin

  2024cites this paper
• Safety pharmacology of acute psilocybin administration in healthy participants

  2024cites this paper
• Pharmaco-toxicological effects of the novel tryptamine hallucinogen 5-MeO-MiPT on motor, sensorimotor, physiological, and cardiorespiratory parameters in mice—from a human poisoning case to the preclinical evidence

  2024cites this paper
• Intoxication of dogs and cats with common stimulating, hallucinogenic and dissociative recreational drugs

  2023cites this paper
• Psychedelia: The interplay of music and psychedelics

  2023cites this paper
• Cardiovascular safety of psychedelic medicine: current status and future directions

  2023cites this paper
• Mechanisms and molecular targets surrounding the potential therapeutic effects of psychedelics

  2023cites this paper
• History repeating: guidelines to address common problems in psychedelic science

  2023cites this paper
• Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers

  2023influential citation
• Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants

  2023cites this paper
• Classics in Chemical Neuroscience: Dextromethorphan (DXM).

  2023cites this paper
• Psilocybin’s effects on cognition and creativity: A scoping review

  2023cites this paper
• Ecstatic or Mystical Experience through Epilepsy

  2023cites this paper
• Assessment of the acute effects of 2C-B vs psilocybin on subjective experience, mood and cognition

  2023cites this paper
• Effect of LSD and music on the time-varying brain dynamics

  2023cites this paper
• Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research

  2022cites this paper
• Human Cortical Serotonin 2A Receptor Occupancy by Psilocybin Measured Using [11C]MDL 100,907 Dynamic PET and a Resting-State fMRI-Based Brain Parcellation

  2022cites this paper
• Adverse effects of psychedelics: From anecdotes and misinformation to systematic science

  2022cites this paper
• The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)

  2022cites this paper
• Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects

  2022cites this paper
• Predictors and potentiators of psychedelic-occasioned mystical experiences

  2022cites this paper
• Human behavioral pharmacology of psychedelics.

  2022cites this paper
• Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms

  2022cites this paper
• If the doors of perception were cleansed, would chronic pain be relieved? Evaluating the benefits and risks of psychedelics.

  2022cites this paper
• The altered state of consciousness induced by Δ9-THC.

  2022cites this paper
• Group VR experiences can produce ego attenuation and connectedness comparable to psychedelics

  2022influential citation
• Self-Actualization and the Integration of Psychedelic Experience: The Mediating Role of Perceived Benefits to Narrative Self-Functioning

  2022cites this paper
• Pharmacological, Neural, and Psychological Mechanisms underlying Psychedelics: A Critical Review.

  2022cites this paper
• placebo run 3 vs. run 1

  2022influential citation
• A Research Domain Criteria (RDoC)-Guided Dashboard to Review Psilocybin Target Domains: A Systematic Review

  2022cites this paper
• Structure-Activity Relationships for Psilocybin, Baeocystin, Aeruginascin, and Related Analogues to Produce Pharmacological Effects in Mice.

  2022cites this paper
• The Altered States Database: Psychometric data from a systematic literature review

  2022cites this paper
• Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?

  2022cites this paper
• Dose–response relationships of psilocybin-induced subjective experiences in humans

  2021cites this paper
• Optimal dosing for psilocybin pharmacotherapy: Considering weight-adjusted and fixed dosing approaches

  2021influential citation
• Psychedelic Therapy's Transdiagnostic Effects: A Research Domain Criteria (RDoC) Perspective

  2021cites this paper
• Psychedelics, placebo effects, and set and setting: Insights from common factors theory of psychotherapy

  2021cites this paper
• Models of psychedelic drug action: modulation of cortical-subcortical circuits.

  2021cites this paper
• Brain entropy, fractal dimensions and predictability: A review of complexity measures for EEG in healthy and neuropsychiatric populations

  2021cites this paper
• Safety pharmacology of acute LSD administration in healthy subjects

  2021cites this paper
• Consciousness in active inference: Deep self-models, other minds, and the challenge of psychedelic-induced ego-dissolution

  2021cites this paper
• Spontaneous Spiritual Awakenings: Phenomenology, Altered States, Individual Differences, and Well-Being

  2021cites this paper
• Pharmacologic Similarities and Differences Among Hallucinogens

  2021cites this paper
• Dissolving yourself in connection to others: shared experiences of ego attenuation and connectedness during group VR experiences can be comparable to psychedelics

  2021influential citation
• Effect of dextromethorphan in the mouse forced swim and tail suspension tests: Evidence for involvement of the alpha receptors

  2021cites this paper
• Addiction of Hallucinogens, Dissociatives, Designer Drugs and “Legal Highs”: Update on Potential Therapeutic Use

  2020cites this paper
• Isness: Using Multi-Person VR to Design Peak Mystical Type Experiences Comparable to Psychedelics

  2020cites this paper
• Psychedelic Research and the Need for Transparency: Polishing Alice’s Looking Glass

  2020cites this paper
• How does it feel to be on psilocybin? Dose-response relationships of subjective experiences in humans

  2020cites this paper
• Subjective features of the psilocybin experience that may account for its self-administration by humans: a double-blind comparison of psilocybin and dextromethorphan

  2020cites this paper
• Psilocybin acutely alters the functional connectivity of the claustrum with brain networks that support perception, memory, and attention

  2020cites this paper
• Dextromethorphan and bupropion reduces high level remifentanil self-administration in rats.

  2020cites this paper
• Experience of Music Used With Psychedelic Therapy: A Rapid Review and Implications.

  2020cites this paper
• Rostral Anterior Cingulate Thickness Predicts the Emotional Psilocybin Experience

  2020cites this paper
• Emotions and brain function are altered up to one month after a single high dose of psilocybin

  2020cites this paper
• Subtle Sensing: Detecting Differences in the Flexibility of Virtually Simulated Molecular Objects

  2020cites this paper
• Psilocybin Induces Time-Dependent Changes in Global Functional Connectivity.

  2020cites this paper
• Long-term Dextromethorphan Use and Acute Intoxication Results in an Episode of Mania and Autoenucleation.

  2020cites this paper
• Potential for limited reinforcing and abuse-related subjective effects of intranasal oxytocin

  2020cites this paper
• Psychedelics and Psychotherapy

  2020cites this paper
• Effects of a single dose of psilocybin on behaviour, brain 5-HT2A receptor occupancy and gene expression in the pig.

  2020cites this paper
• Neurotoxicology Syndromes Associated with Drugs of Abuse.

  2020cites this paper
• Inhaled 5-methoxy-N,N-dimethyltryptamine: Supportive context associated with positive acute and enduring effects

  2019cites this paper
• [Safety signal detection by the French Addictovigilance Network: Innovative methods of investigation, examples and usefulness for public health].

  2019cites this paper
• Mystical and Other Alterations in Sense of Self: An Expanded Framework for Studying Nonordinary Experiences

  2019cites this paper
• LIMITATIONS ON THE SCIENTIFIC STUDY OF DRUG‐ENABLED MYSTICAL EXPERIENCES

  2019cites this paper
• REBUS and the Anarchic Brain: Toward a Unified Model of the Brain Action of Psychedelics

  2019influential citation
• Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

  2019cites this paper
• Awe: a putative mechanism underlying the effects of classic psychedelic-assisted psychotherapy

  2018cites this paper